| Indicators | Browse All

eXoZymes, Inc. (EXOZ)

Healthcare | Biotechnology | Monrovia, United States | NasdaqCM
7.17 USD -0.01 (-0.102%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 7.25 +0.08 (1.148%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 4:56 a.m. EDT

The immediate outlook is neutral despite a recent bounce. While the stock has rallied from its lows to trade above the 50-day average, the underlying business fundamentals are severely impaired. The company is burning significant cash with negative operating and free cash flows, posting substantial losses on both assets and equity, and trading at a premium price-to-book multiple that suggests the market is pricing in future success that hasn't materialized yet. The recent surge appears driven by specific catalysts like the NIH grant and public offerings rather than a turnaround in core operations. With no price history available to confirm a multi-year trend and zero dividends to provide income, there is no clear directional edge for either the short or long term.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.178214
MSTL0.180396
AutoTheta0.180883
AutoARIMA0.182693

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 38%
H-stat 0.23
Ljung-Box p 0.000
Jarque-Bera p 0.240
Excess Kurtosis -1.22
Attribute Value
Sector Healthcare
Debt to Equity Ratio 29.694
Market Cap 66,525,996
Previous Name Invizyne Technologies, Inc.
Website https://www.exozymes.com

Info Dump

Attribute Value
52 Week Change -0.25969875
Address1 750 Royal Oaks Drive
Address2 Suite 106
All Time High 23.99
All Time Low 4.35
Ask 7.6
Ask Size 1
Average Daily Volume10 Day 5,750
Average Daily Volume3 Month 9,514
Average Volume 9,514
Average Volume10Days 5,750
Bid 8.2
Bid Size 9
Book Value 0.394
City Monrovia
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 7.1677
Current Ratio 3.813
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 7.38
Day Low 6.71
Debt To Equity 29.694
Display Name eXoZymes
Earnings Call Timestamp End 1,747,083,600
Earnings Call Timestamp Start 1,747,083,600
Earnings Timestamp End 1,747,047,540
Earnings Timestamp Start 1,747,047,540
Ebitda -10,262,264
Ebitda Margins 0.0
Enterprise To Ebitda -6.037
Enterprise Value 61,958,336
Eps Trailing Twelve Months -1.2
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 6.3846
Fifty Day Average Change 0.78309965
Fifty Day Average Change Percent 0.12265445
Fifty Two Week Change Percent -25.969875
Fifty Two Week High 18.4
Fifty Two Week High Change -11.2323
Fifty Two Week High Change Percent -0.6104511
Fifty Two Week Low 4.35
Fifty Two Week Low Change 2.8177
Fifty Two Week Low Change Percent 0.6477471
Fifty Two Week Range 4.35 - 18.4
Financial Currency USD
First Trade Date Milliseconds 1,731,508,200,000
Float Shares 7,137,922
Free Cashflow -3,252,423
Full Exchange Name NasdaqCM
Full Time Employees 32
Fullday Change -0.00730038
Fullday Change Percent -0.101747
Fullday Price 7.25
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.64889
Held Percent Institutions 0.01339
Implied Shares Outstanding 9,281,359
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Long Name eXoZymes, Inc.
Market us_market
Market Cap 66,525,996
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1687004448
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-08-29
Net Income To Common -10,190,888
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 66,593,750
Open 7.01
Operating Cashflow -6,995,227
Operating Margins 0.0
Payout Ratio 0.0
Phone 626 415 1488
Post Market Change 0.082300186
Post Market Change Percent 1.1482092
Post Market Price 7.25
Post Market Time 1,787,959,804
Prev Name Invizyne Technologies, Inc.
Previous Close 7.175
Price Hint 2
Price To Book 18.192131
Profit Margins 0.0
Quick Ratio 3.63
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.007300377
Regular Market Change Percent -0.10174741
Regular Market Day High 7.38
Regular Market Day Low 6.71
Regular Market Day Range 6.71 - 7.38
Regular Market Open 7.01
Regular Market Previous Close 7.175
Regular Market Price 7.1677
Regular Market Time 1,787,947,200
Regular Market Volume 2,688
Return On Assets -0.74738
Return On Equity -1.87164
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 9,281,359
Shares Percent Shares Out 0.0021
Shares Short 19,516
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 19,579
Short Name eXoZymes Inc.
Short Percent Of Float 0.004
Short Ratio 2.76
Source Interval 15
State CA
Symbol EXOZ
Total Cash 5,652,696
Total Cash Per Share 0.609
Total Debt 1,085,035
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.2
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 9.563225
Two Hundred Day Average Change -2.395525
Two Hundred Day Average Change Percent -0.25049344
Type Disp Equity
Volume 2,688
Website https://www.exozymes.com
Zip 91,016